Epilepsy Drug Sulthiame Shows Promise in Treating Obstructive Sleep Apnoea
Breakthrough Findings on Sleep Disorder Treatment
In recent studies conducted by Swedish researchers, it was found that the epilepsy medication Sulthiame can lead to a significant decrease in obstructive sleep apnoea symptoms.
Study Results
- The study demonstrated that patients taking Sulthiame experienced a 40 percent reduction in symptoms compared to those receiving a placebo.
- These findings suggest that Sulthiame may offer a new and effective treatment option for those suffering from obstructive sleep apnoea.
Implications for Patients
This potential treatment opens doors for better management of sleep disorders and improves quality of life for affected individuals.
Disclaimer: The information provided on this site is for informational purposes only and is not intended as medical advice. We are not responsible for any actions taken based on the content of this site. Always consult a qualified healthcare provider for medical advice, diagnosis, and treatment. We source our news from reputable sources and provide links to the original articles. We do not endorse or assume responsibility for the accuracy of the information contained in external sources.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.